Bone Neoplasms

18 registered clinical trials studyying Bone Neoplasms — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Investigation Into the Safety and Efficacy of ICG-Labeled Fluorescence Imaging Technology in Guiding the Resec NCT06979115	Guangdong Provincial People's Hospital	—
Completed	Ewing Sarcoma Family of Tumors (ESFT): A 15-year Experience From a Tertiary Care Cancer Center in Upper Egypt NCT04300179	Assiut University	—
Recruiting	Radiotherapy Treatments for Neoplasms of the Limbs NCT06335251	European Institute of Oncology	—
Completed	Localized Osteosarcoma in Upper Egypt: A Clinical Prediction Model NCT03839095	Assiut University	—
Completed	Malignant Pediatric Soft Tissue & Bone Tumors of the Extremities: A Retrospective Study NCT02557243	Assiut University	—
Completed	Pilot Study of Stereotactic Ablation for Oligometastatic Breast Neoplasia in Combination With the Anti-PD-1 An NCT02303366	Peter MacCallum Cancer Centre, Australia	Phase 1
Recruiting	An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry NCT02677961	Ohio State University Comprehensive Cancer Center	—
Completed	Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoled NCT02274623	OPKO Health, Inc.	Phase 1
Completed	The Palliative Radiotherapy And Inflammation Study - PRAIS NCT02107664	Norwegian University of Science and Technology	—
Completed	Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY) NCT01479283	McMaster University	Phase 3
Withdrawn	Using Mesenchymal Stem Cells to Fill Bone Void Defects in Patients With Benign Bone Lesions NCT00851162	Emory University	Phase 2 / Phase 3
Completed	Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone D NCT00558272	AstraZeneca	Phase 2
Completed	Bonefos and the Consumption of Analgesics NCT00909142	Bayer	—
Completed	Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases NCT00434447	Novartis Pharmaceuticals	Phase 4
Terminated	A Study To Evaluate Pregabalin In The Treatment Of Moderate To Severe Chronic Bone Pain Related To Metastatic NCT00381095	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 4
Withdrawn	Safety and Efficacy of an Investigational Drug Versus Placebo in the Treatment of Cancer Pain (0663-083) NCT00095017	Organon and Co	Phase 2
Completed	FREE Study - Fracture Reduction Evaluation NCT00211211	Medtronic Spine LLC	Phase 4
Completed	Helical Tomotherapy as a Radiotherapy Technique for Treating Bone Metastases NCT00168129	Alberta Health services	Phase 1